SCHEMBL4841005

SCHEMBL4841005

COc1ccc2c(c1)C(=CC(=O)c1ccc(NC(C)=O)cc1)NC(C)(C)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 3/20 0.47
ALDH1A1 P00352 7/20 0.43
HTT P42858 4/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 3/20 0.41
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2D6 P10635 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 1/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4840991 1.00 MAPT (0.47) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4839986 0.93 KDM4E (0.42) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4839999 0.93 KDM4E (0.42) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4839109 0.91 RAB9A (0.49) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4834848 0.91 KMT2A (0.43) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4834829 0.91 KMT2A (0.43) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4839102 0.91 RAB9A (0.49) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4834906 0.91 MAPT (0.41) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4834891 0.91 MAPT (0.41) MAPTNPC1RAB9AALDH1A1HTT
SCHEMBL4842373 0.90 LMNA (0.40) MAPTNPC1RAB9AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US claimed
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 MAPT 646/4885NPC1 985/4885RAB9A 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.